Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ritchie

Showing results (241-250 of 265) with videos related to

Pageof 27
Sort By:
Diabetologia|September 25, 2012
Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetesR H Ritchie, J E Love, K Huynh, et al.
Current Biology : CB|January 13, 2009
Distinctive Paleo-Indian migration routes from Beringia marked by two rare mtDNA haplogroupsUgo A Perego, Alessandro Achilli, Norman Angerhofer, et al.
Communications Biology|July 6, 2025
Annexin-A1 deficiency uncovers female-specific pathways in blood pressure control and cardiovascular remodeling in miceJaideep Singh, Kristy L Jackson, Haoyun Fang, et al.
Scientific Reports|February 7, 2018
Diastolic dysfunction is more apparent in STZ-induced diabetic female mice, despite less pronounced hyperglycemiaChanchal Chandramouli, Melissa E Reichelt, Claire L Curl, et al.
Journal of Sport and Health Science|October 16, 2025
Influence of diet-induced obesity and voluntary exercise training on cardiac lipids and mitochondrial function in miceNimna Perera, Minh Deo, Surafel Tegegne, et al.
Cardiovascular Drugs and Therapy|February 17, 2020
Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic HeartMitchel Tate, Gavin C Higgins, Miles J De Blasio, et al.
Cardiovascular Drugs and Therapy|October 27, 2019
The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic HeartMitchel Tate, Gavin C Higgins, Miles J De Blasio, et al.
Iscience|September 22, 2023
Mapping the cellular and molecular landscape of cardiac non-myocytes in murine diabetic cardiomyopathyCharles D Cohen, Miles J De Blasio, Gabriella E Farrugia, et al.
Cardiovascular Diabetology|June 2, 2021
Diastolic dysfunction in a pre-clinical model of diabetes is associated with changes in the cardiac non-myocyte cellular compositionCharles D Cohen, Miles J De Blasio, Man K S Lee, et al.
Frontiers in Pharmacology|April 20, 2019
Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac<sub>2-26</sub>, Against Myocardial InfarctionCheng Xue Qin, Sarah Rosli, Minh Deo, et al.
Pageof 27

Showing results (241-250 of 265) with videos related to

Sort By:
Pageof 27
Diabetologia|September 25, 2012
Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetesR H Ritchie, J E Love, K Huynh, et al.
Current Biology : CB|January 13, 2009
Distinctive Paleo-Indian migration routes from Beringia marked by two rare mtDNA haplogroupsUgo A Perego, Alessandro Achilli, Norman Angerhofer, et al.
Communications Biology|July 6, 2025
Annexin-A1 deficiency uncovers female-specific pathways in blood pressure control and cardiovascular remodeling in miceJaideep Singh, Kristy L Jackson, Haoyun Fang, et al.
Scientific Reports|February 7, 2018
Diastolic dysfunction is more apparent in STZ-induced diabetic female mice, despite less pronounced hyperglycemiaChanchal Chandramouli, Melissa E Reichelt, Claire L Curl, et al.
Journal of Sport and Health Science|October 16, 2025
Influence of diet-induced obesity and voluntary exercise training on cardiac lipids and mitochondrial function in miceNimna Perera, Minh Deo, Surafel Tegegne, et al.
Cardiovascular Drugs and Therapy|February 17, 2020
Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic HeartMitchel Tate, Gavin C Higgins, Miles J De Blasio, et al.
Cardiovascular Drugs and Therapy|October 27, 2019
The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic HeartMitchel Tate, Gavin C Higgins, Miles J De Blasio, et al.
Iscience|September 22, 2023
Mapping the cellular and molecular landscape of cardiac non-myocytes in murine diabetic cardiomyopathyCharles D Cohen, Miles J De Blasio, Gabriella E Farrugia, et al.
Cardiovascular Diabetology|June 2, 2021
Diastolic dysfunction in a pre-clinical model of diabetes is associated with changes in the cardiac non-myocyte cellular compositionCharles D Cohen, Miles J De Blasio, Man K S Lee, et al.
Frontiers in Pharmacology|April 20, 2019
Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac<sub>2-26</sub>, Against Myocardial InfarctionCheng Xue Qin, Sarah Rosli, Minh Deo, et al.
Pageof 27